USE OF I-131-CEA ANTIBODY AS A TUMOR SCANNING AGENT

被引：0
|
作者：
HOFFER, PB
LATHROP, K
BEKERMAN, C
FANG, VS
REFETOFF, S
机构：
[1] UNIV CHICAGO,FRANKLIN MCLEAN MEM RES INST,CHICAGO,IL
[2] UNIV CHICAGO,PRITZKER SCH MED,DEPT RADIOL,950 E 59TH ST,CHICAGO,IL 60637
来源：
JOURNAL OF NUCLEAR MEDICINE | 1974年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：323 / 327
页数：5
相关论文
共 50 条
  • [21] METASTATIC LOCALIZATION WITH I-131 ANTI-CEA ANTIBODY IN COLORECTAL-CARCINOMA PATIENTS
    ABDELNABI, HH
    HINKLE, GH
    MOJZISIK, CM
    THURSTON, MO
    OLSEN, JO
    MARTIN, EW
    CLINICAL NUCLEAR MEDICINE, 1985, 10 (09) : P22 - P22
  • [22] USE OF I-131 IODIPAMIDE FOR BRAIN TUMOR DETECTION
    NORDYKE, RA
    GOEBERT, HW
    JOURNAL OF NUCLEAR MEDICINE, 1964, 5 (05) : 377 - 377
  • [23] Tumor angiogenesis imaging agent: biodistribution of 131I-YG5 and 131I-Boc-YG5
    Sun Xin
    Chu Taiwei
    Wang Xiangyun
    NUCLEAR SCIENCE AND TECHNIQUES, 2010, 21 (05) : 302 - 305
  • [24] THE USE OF 2ND ANTIBODY TO ACCELERATE THE CLEARANCE OF THERAPEUTIC DOSES OF I-131 LABELED GOAT ANTI-CEA IN PATIENTS
    LEDERMANN, JA
    BEGENT, RHJ
    SEARLE, F
    GREEN, A
    BAGSHAWE, KD
    GLASER, MG
    DALE, RG
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 655 - 655
  • [25] Tumor angiogenesis imaging agent:biodistribution of 131I-YG5 and 131I-Boc-YG5
    SUN Xin CHU Taiwei WANG Xiangyun Beijing National Laboratory for Molecular Sciences
    NuclearScienceandTechniques, 2010, 21 (05) : 302 - 305
  • [26] DISTRIBUTION OF 131I LABELED DIETHYLSTILBESTROL DIPHOSPHATE IN ANIMALS AND MEN WITH OBSERVATIONS ON ITS POTENTIAL USE AS A SCANNING AGENT OF PROSTATE
    TUBIS, M
    ENDOW, JS
    BLAHD, WH
    NUCLEAR-MEDIZIN, 1967, 6 (02): : 184 - &
  • [27] Fractionated 131I-Anti-CEA RIT
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (10) : 35N - 35N
  • [28] TUMOR IMAGING IN MICE WITH I-131 LABELED MONOCLONAL-ANTIBODY
    LEVINE, G
    BALLOU, B
    REILAND, J
    SOLTER, D
    GUMERMAN, LW
    HAKALA, T
    JOURNAL OF NUCLEAR MEDICINE, 1980, 21 (06) : P54 - P54
  • [29] Clinical optimization of two-step radioimmunotherapy (RAIT) using an 131I-labeled anti-CEA/anti-DTPA bispecific antibody and an 131I-labeled bivalent DTPA hapten in patients with CEA-expressing tumor.
    Kraeber-Bodere, F
    Faivre-Chauvet, A
    Cerato, E
    Devillers, A
    Sharkey, RM
    Chang, K
    Goldenberg, DM
    Barbet, J
    Chatal, JF
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 123P - 123P
  • [30] Radioimmunotherapy of Human Colon Cancer Xenografts with 131I-Labeled Anti-CEA Monoclonal Antibody
    Liu, Zhaofei
    Jin, Cunjing
    Yu, Zilin
    Zhang, Jing
    Liu, Yan
    Zhao, Huiyun
    Jia, Bing
    Wang, Fan
    BIOCONJUGATE CHEMISTRY, 2010, 21 (02) : 314 - 318
12345